Join us for an exclusive evening in Boston focused on the strategic partnerships and innovations driving success in cell and gene therapy development.
Our CEO, Jason C. Foster, will lead an expert panel discussion titled, ‘The CGT Success Blueprint: Strategic collaboration, best-of-breed technology, and scientific excellence’.
The panel will discuss how strategic alliances, cutting-edge manufacturing solutions, and breakthrough technologies are transforming the journey from research to market for cell and gene therapies.
Joining Jason will be:
Dr. Bruce Thompson, Chief Technology Officer at Kincell Bio
Lucy Foley, Chief Executive Officer at eXmoor Pharma
Aaron Vernon, Chief Medical Officer at Quell Therapeutics
Dr. Magdi Elsallab, MD, PhD from Mass General Cancer Center